SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AlloVir, Inc. (ALVR) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 44/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ALVR
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.85
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-79,765,000.00 |
$1.14M |
$-2.43M |
-214.1% |
| 2019 |
$-16.93 |
$165K |
$-23.84M |
-14447.9% |
| 2020 |
$-2.59 |
$0.00 |
$-69.78M |
- |
| 2021 |
$-2.74 |
$0.00 |
$-171.96M |
- |
| 2022 |
$-2.20 |
$0.00 |
$-168.71M |
- |
| 2023 |
$-1.83 |
$0.00 |
$-190.42M |
- |
| 2024 |
$-0.51 |
$0.00 |
$-58.77M |
- |
| 2025 |
$-2.85 |
$0.00 |
$-43.44M |
- |
